United States-Russian Federation: Agreement between the Government of the United States of America and the Government of the Russian Federation on Scientific and Technical Cooperation in the Management of Plutonium that has been withdrawn from Nuclear Military Programs

1998 ◽  
Vol 37 (6) ◽  
pp. 1296-1301
Author(s):  
A. G. Barabashev ◽  
D. V. Ponomareva

The paper is a review of the regulatory framework of the Russian-American cooperation in science and technology. The authors analyse the interstate and intergovernmental agreements concluded by Russia and the United States in this field (1992 Agreement between the Russian Federation and the United States of America on Cooperation in the exploration and use of outer space for peaceful purposes, 1993 Science and Technology Cooperation Agreement between the Government of the Russian Federation and the Government of the United States of America, 2013 Agreement between the Government of the United States of America and the Government of the Russian Federation On cooperartion in nuclear- and energy-related scientific research and development). The paper highlights the key problems of legal regulation and provides specific examples of the implementation of the provisions of bilateral agreements, in particular, joint Russian-American projects in the area of space, scientific, technological and educational cooperation (the program «Soyuz-Apollon», international project «International Space Station», the Russian Academy of Sciences and the US scientific institutions cooperation agreements). In conclusion, an attempt is made to identify the main trends in the development of the legal framework for cooperation between Russia and the United States in the scientific and technological field.


Author(s):  
D.S. Yurochkin ◽  
◽  
A.A. Leshkevich ◽  
Z.M. Golant ◽  
I.A. NarkevichSaint ◽  
...  

The article presents the results of a comparison of the Orphan Drugs Register approved for use in the United States and the 2020 Vital and Essential Drugs List approved on October 12, 2019 by Order of the Government of the Russian Federation No. 2406-r. The comparison identified 305 international non-proprietary names relating to the main and/or auxiliary therapy for rare diseases. The analysis of the market of drugs included in the Vital and Essential Drugs List, which can be used to treat rare (orphan) diseases in Russia was conducted.


2018 ◽  
Vol 14 (2) ◽  
pp. 259-268
Author(s):  
Magdalena SKWARSKA

The article presents the development of Russian foreign policy towards NATO and EU over the course of last few years. Special attention has been given to the most aggressive measures implemented by Moscow in order to preserve its importance in world political landscape. Author appeals to the Crimea case, military development, hybrid and information warfare and cases of assassinations of Russian emigrants linked to the opposition and business.


Sign in / Sign up

Export Citation Format

Share Document